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Abstract
The current approach to the management of emotions in 
patients with cancer is “distress screening and referral 
for the provision of psychosocial care.” Although this 
approach may have certain beneficial effects, screening and 
referral programs have shown a limited effect on patient 
psychological well-being. We argue that this limited effect is 
due to a mismatch between patient needs and the provision 
of care, and that a fundamental reconceptualization of the 
clinical management of emotions in patients with cancer 
is needed. We describe the rationale and characteristics of 
“emotional support and case finding” as the approach to the 
management of emotions in patients with cancer. The two 
main principles of the approach are: (1) Emotional support: 
(a) The treating team, consisting of doctors, nurses, and 
allied health staff, is responsive to the emotional needs of 
patients with cancer and provides emotional support. (b) 
The treating team provides information on external sources 
of emotional support. (2) Case finding: The treating team 
identifies patients in need of mental health care by means 
of case finding, and provides a referral to mental health 
care as indicated. We present a novel perspective on how 
to organize the clinical management of emotions in patients 
with cancer. This is intended to contribute to a fruitful 
discussion and to inform an innovative research agenda on 
how to manage emotions in patients with cancer.
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DISTRESS SCREENING AND REFERRAL PROGRAMS
Distress refers to “a multifactorial unpleasant emo-
tional experience of a psychological (i.e. cognitive, 
behavioral, emotional), social, and/or spiritual 
nature that may interfere with the ability to cope ef-
fectively with cancer, its physical symptoms, or its 
treatment” [1]. The term “distress” was introduced 
because it was considered to be more acceptable 
and less stigmatizing than psychiatric and psycho-
logical terminology [2]. Alternatively, traditional 
psychiatric diagnostic categories can be used to de-
scribe patients’ mental response to the diagnosis and 
treatment of cancer. The primary focus is usually 
on anxiety and mood disorders; occasionally, other 
mental disorders are included as well [3]. Distress 
is very common among patients with cancer, irre-
spective of terminology, underlying theory, and 
associated assessment. In patients in the active anti-
tumor phase of treatment, reported prevalence rates 
are 18% for anxiety or mood disorders [4], 30%–40% 
for any combination of anxiety, mood, or adjustment 
disorders [5], 32% for any mental disorder [3], and 
35%–52% for general distress [6, 7]. The identifica-
tion and treatment of distress are a clinical priority 
because distress is a risk factor for non-adherence to 
medical treatment [8] and for a poor outcome in the 
physical, mental, and social life domains [9].
Currently, “distress screening and referral for the 
provision of psychosocial care” is the dominant ap-
proach to the management of distress. This approach 
comprises the identification of distress by means of a 
distress-screening tool, provision of support by the 
treating team in case of mild distress, and referral 
to psychosocial care for patients with moderate or 
severe distress [1]. Guidelines issued in a broad 
range of countries recommend distress screening 
and referral to psychosocial care in patients with 
cancer [1, 10–13]. This approach may indeed have 
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Implications
Practice: The role of the treating team in the 
management of emotions in patients with cancer 
is pivotal. Mental health professionals mainly 
have an indirect role: they work through the 
treating team. Direct treatment occurs only in 
selected patients.
Policy: We recommend to revise existing guide-
lines, based on this approach.
Research: This approach informs an innovative 
research agenda on how to improve the clinical 
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certain beneficial effects (e.g., identification of dis-
tressed patients, or more doctor–patient communi-
cation about distress [14, 15]). However, screening 
and referral programs have shown a limited effect 
on patient psychological well-being [16–19]. A  re-
cent Cochrane review concluded that, although 
the certainty of the evidence is low and interven-
tion and study characteristics were heterogeneous, 
the evidence does not support the effectiveness of 
screening of psychosocial well-being and care needs 
in patients with cancer [17]. Two recent studies not 
yet included in previous reviews reported similar re-
sults. In our recent randomized trial, we examined 
the outcome of a screening and referral program to 
identify and treat psychological distress in patients 
with metastasized colorectal cancer, comparing out-
comes to usual care [16, 20]. We carefully created 
optimal conditions to ensure that the screening and 
referral program would be maximally effective. 
Nevertheless, the screening and referral program 
did not result in a reduction in psychological distress 
[16]. Another recent trial also failed to demonstrate 
a beneficial effect on global quality of life [21]. It 
should be noted that treatment of psychological 
distress per se is effective [22]; it is the current ap-
proach to identifying patients in need of treatment 
(i.e., distress screening and referral) which generally 
had a limited effect on psychological well-being.
A common response to these findings has been 
to advocate better implementation of screening and 
referral programs [23–30]. For example, use of an 
effective change management strategy, leadership, 
integration, customization, project management, 
and program evaluation has been recommended 
[23]. Other researchers have noted the heterogen-
eity in definitions and theoretical conceptualizations 
of distress, procedures for screening and referral, 
interventions, and outcomes [17, 30, 31]. This het-
erogeneity may have obscured beneficial effects of 
screening and referral programs. Beneficial effects 
could become discernible once the various features 
of the screening approaches are carefully disentan-
gled. Although well intended, we believe that such 
efforts are unlikely to be effective. The main reason 
is that many patients with cancer are unwilling to ac-
cept a referral for psychosocial care and we believe 
that this is due to a mismatch between patient needs 
and the provision of care.
In our own study [16], 60% of patients showed 
elevated distress during at least one of the 
screening time points. Nevertheless, only 15% 
chose watchful waiting and a mere 11% accepted 
active mental health care (consisting of guided 
self-help, face-to-face problem-solving therapy, or 
a referral to professional mental health care). This 
low uptake of mental health care resulted in the 
screening and referral arm of the trial showing no 
improvement of psychological distress compared 
to the usual care arm. Low uptake of psychosocial 
care has been observed in several studies, in a 
range of countries and in several clinical settings 
[32]. In a UK-based study, only 36% of patients with 
elevated distress scores indicated a need for pro-
fessional help with emotional problems [33]. An 
Australian study found that only 30% of distressed 
patients reported a need for help with distress [34]. 
In a USA-based study, screening was implemented 
to identify patients with distress: of the patients 
who screened positive for distress, only 14% had 
actually completed at least one appointment with 
the supportive care team after 14  days follow-up 
[35]. Finally, in a review of barriers to the delivery 
of psychosocial care in patients with cancer “no 
need for psychosocial services and support” was 
the most frequently reported barrier (reported by 
39% of patients) [36]. Low uptake of psychosocial 
care, thus, seems to be a universal phenomenon. 
In view of this fact, we are skeptical that better im-
plementation would result in effective programs 
for distress screening and referral. We would 
argue that a fundamental reconceptualization of 
the management of distress in patients with cancer 
seems to be warranted.
EMOTIONS
Distress is defined as an “unpleasant emotional ex-
perience” [1]. Distress refers to emotions and nega-
tive emotions in particular. For reasons of clarity, 
in the remainder of the paper, we will use the term 
“emotions.” These include negative emotions such 
as fear, anxiety, depression, and hostility, but also 
positive emotions such as happiness, hope, and 
calmness.
Human emotions have developed through the 
course of evolution because they facilitate adap-
tation to important events [37]. Emotions alert, 
motivate and prepare us to deal with these events 
[38]. For example, fear causes cognitive, behav-
ioral, and physiological changes which help to 
face a threatening event [37]. Sadness turns our 
attention inwards, promoting resignation and ac-
ceptance. The expression of sadness may elicit 
sympathy and support from other people [39]. 
Emotions are essentially adaptive—they help us to 
adapt to events in the environment, such as the 
diagnosis and treatment of cancer [32]. In contrast, 
emotions sometimes hamper adaptation, leading 
to significant distress and disability [40]. Emotions 
are maladaptive if they are disproportionally se-
vere or persistent, and if they interfere with func-
tioning. Examples include severe anxiety leading 
to the avoidance of cancer treatment, depression 
leading to unrealistic negative expectations and 
lack of motivation to continue treatment, or fear 
of death leading to unrealistic optimism regarding 
the outcome of further treatment.
Identification of patients with clinically relevant 
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responses. The Distress Thermometer and other 
questionnaires use a cutoff score for the intensity 
of emotions; if patients score above the cutoff, they 
are considered to be distressed [1]. The underlying 
assumption is that a low intensity of emotions is 
to be preferred, that is, “less is better” [32]. The 
question arises whether this assumption is correct. 
Indeed, some patients scoring above the cutoff may 
experience maladaptive emotions. However, other 
patients scoring above the cutoff may actually ex-
perience adaptive emotions which facilitate coping 
with cancer. In general, a strong emotional experi-
ence in response to cancer is natural and poten-
tially adaptive. Thus, equating an intense emotion 
with a maladaptive emotion is not a valid approach. 
Further research is needed to identify indicators that 
can differentiate between adaptive and maladaptive 
emotions in patients with cancer [41]. Psychological 
and psychiatric theories on emotions and mental dis-
orders may guide the development of operational 
indicators that can distinguish between adaptive and 
maladaptive emotions, in addition to clinical criteria 
[40] and a patient’s personal evaluation of their own 
emotions. For example, the theory on emotion dy-
namics predicts that patients with maladaptive emo-
tions are characterized by emotional symptoms that 
linger and perpetuate more across time, are more 
extreme, or are more unstable, compared to patients 
with adaptive emotions [42]. If confirmed in pa-
tients with cancer, an operational indicator could be 
developed to assess whether emotions are lingering, 
extreme, or unstable (instead of whether emotions 
are intense).
MATCHING THE PROVISION OF CARE TO 
PATIENTS’ NEEDS
We believe that the low uptake of mental health 
care is due to a mismatch between patient needs 
and the provision of care [32]. Patients experiencing 
adaptive emotions are expected to prefer to handle 
their emotions themselves [43–46]. They may wel-
come support from relatives, friends, peers, and pri-
mary care-givers (i.e., doctors and nurses). Patients 
with adaptive emotions can be expected to refuse 
a referral to mental health care; that is, care that 
primarily focuses on treating emotional problems. 
In contrast, professional mental health care such 
as psychotherapy or pharmacotherapy is indicated 
only in patients experiencing maladaptive emotions 
[47, 48]. We believe that matching the provision of 
care to the nature of emotions is in line with patients’ 
emotional needs: supportive interventions in case of 
adaptive emotions, and professional mental health 
care in case of maladaptive emotions [32].
EMOTIONAL SUPPORT AND CASE FINDING
These considerations regarding emotions, and 
matching of care to the nature of emotions (adaptive 
vs. maladaptive emotions) rather than the intensity of 
emotions, have led us to propose a new approach to 
the management of emotions in patients with cancer. 
We call this approach “emotional support and case 
finding” (see Box 1).
Emotional support
Cancer is a life-threatening disease, its treatment is 
demanding and burdensome, it is associated with 
powerful emotions, and approximately one-third of 
patients fulfill the criteria of a mental disorder [3] 
or experience distress [6]. Nevertheless, the majority 
of patients with cancer display resilience: they adapt 
and are able to cope with cancer. In this respect, 
cancer resembles other potentially traumatic events: 
in the face of such events, humans are remarkably 
resilient and most people maintain an ability to func-
tion effectively [49].
However, the fact that patients are resilient does 
not mean that they have no need for support. In 
contrast, patients may need emotional support from 
relatives, friends, and peers [50–53], as well as the 
treating team consisting of doctors, nurses, and allied 
health staff. A  recent study reported that patients 
perceived the treating team as an important source 
of emotional support [54], and patients felt that the 
treating team understood the burden of disease, 
so that they felt no need to explain the impact of 
disease [54]. Patients valued care that was provided 
with empathy and in accordance with their wishes 
[54]. In our own trial, we observed that enhanced 
discussion of psychosocial concerns by nurses and 
oncologists improved patient well-being [16].
Oncologists recognize the provision of emotional 
support as an important clinical task. It is one of 
the reasons why oncologists are passionate about 
oncology care [55]. Oncologists consider an emo-
tional response to be a normal and natural reaction 
to receiving a cancer diagnosis or being treated for 
cancer [56], and report that they respond to their 
patient’s emotions by establishing a supportive re-
lationship, normalizing the patient’s experience, 
Box 1. Approach to the clinical management 
of cancer-related emotions: Emotional support 
and case finding.
1. Emotional support
(a) The treating team consisting of doctors, nurses, 
and allied health staff is responsive to the emo-
tional needs of patients with cancer and provides 
emotional support.
(b) The treating team provides information on ex-
ternal sources of emotional support.
2. Case finding
 The treating team identifies patients in need of 
mental health care by means of case finding, 
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calming the patient, and maintaining continuity of 
care [57]. Similarly, nurses consider delivery of emo-
tional care and support to patients and their families 
a major component of their work [58].
Emotional support can also be provided by other 
means, including online self-management support 
[59], patient discussion and support groups (peers), 
and expert volunteers [60]. As patients are fre-
quently unaware of these resources [36], informa-
tion on these external resources should be made 
more readily available.
These considerations lead us to propose the 
first principle of the new approach, referred to as 
“emotional support”: (a) The treating team consisting of 
doctors, nurses, and allied health staff is responsive to the 
emotional needs of patients with cancer and provides emo-
tional support. (b) The treating team provides information 
on external sources of emotional support.
Case finding
Some patients with cancer will experience mal-
adaptive emotions, leading to the need for mental 
health care. As argued above, screening is un-
likely to be an effective approach toward the 
identification of patients in need of mental health 
care. We propose that, in place of screening, case 
finding can be used to identify patients in need 
of mental health care [61]. Case finding is to be 
distinguished from screening, both conceptually 
and operationally. Screening is defined as “the ap-
plication of a diagnostic test or clinical assessment 
in order to optimally rule-out those without the 
disorder with minimal false negatives (missed 
cases). Screening is often performed in a large 
population as the first of several diagnostic tests. 
(...) Case finding <is> the application of a diagnostic 
test or clinical assessment in order to optimally 
identify those with the disorder with minimal false 
positives (…). Case finding is often performed in 
a selected population at high risk for the condi-
tion” (p. 150) [62, 63]. In the present context, case 
finding is the purposive identification of patients 
with emotional problems for which a referral for 
mental health care is indicated. Risk factors for 
emotional problems in patients with cancer are 
well established. For example, younger age, lack 
of social support, and a relatively burdensome 
disease or treatment trajectory are well-known risk 
factors for distress [64, 65]. These risk factors war-
rant a clinical examination for case finding. We 
propose “case finding” as the second principle of 
the new approach: The treating team identifies patients 
in need of mental health care by means of case finding, 
and provides a referral to mental health care as indicated.
CONSIDERATIONS REGARDING THE APPROACH
Above, we have presented a dichotomous view of 
emotions: adaptive versus maladaptive. This is a 
simplification, as no absolute distinction between 
adaptive and maladaptive emotions exists. However, 
in clinical practice one needs to make a binary de-
cision: to refer or not to refer the patient for the 
provision of mental health care. For that reason, 
we distinguish between adaptive emotions (no re-
ferral needed) and maladaptive emotions (referral 
needed).
Previous studies have demonstrated a disconnect 
between clinician-rated and patient-reported emo-
tions [66–68]. However, doctors and nurses may be 
more sensitive to patients’ need for mental health 
care than previously reported. In a recent study, 
we assumed that doctors and nurses intuitively dis-
tinguish between adaptive emotions that do not 
require mental health care and maladaptive emo-
tions that do require mental health care. This led 
us to hypothesize that the sensitivity of assessment 
of emotions by doctors and nurses would be higher 
when tested against patients’ need for mental health 
care as a reference standard, compared to patients’ 
emotional distress as a reference standard. This hy-
pothesis was indeed confirmed [69]. This finding 
suggests that the clinical assessment of emotions in 
patients with cancer may be more accurate than pre-
viously reported.
Nevertheless, the accuracy of case finding may 
need to be optimized. Training of the members of 
the team may improve the accuracy of the identifica-
tion of emotional problems. Oncologists and nurses 
have been observed to use various strategies to iden-
tify patients in need of mental health care. These 
include inquiring directly, getting to know the pa-
tient, using intuition and subjective judgment, and 
checking the patient’s medical history [56, 70]. Both 
doctors and nurses have indicated a need for further 
training in the identification of emotional problems 
[56, 70]. Training may thus improve the accuracy 
of case finding. Topics could include criteria for 
emotions to be considered maladaptive (e.g., inter-
ference with doctor–patient communication or 
functioning in daily life), risk factors for emotional 
problems, communication strategies to evaluate 
emotions, and cultural variations in the presentation 
of emotional problems.
The approach presented here is a proposal on 
how to organize care for emotions in patients with 
cancer. In this approach, the role of the treating 
team in the management of emotions in patients 
with cancer is pivotal. An important task for psych-
ologists and other mental health professionals is to 
provide training to the treating team in applying 
this approach: training in providing emotional sup-
port, in differentiating adaptive from maladaptive 
emotions, in identifying patients in need of mental 
health care, and in motivating selected patients to 
accept a referral for mental health care. In some 
cases, mental health professionals provide treatment 
to patients with maladaptive emotions. However, 
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mainly have an indirect role: they work through 
the treating team; direct treatment occurs only in 
selected patients (for a similar approach towards 
exercise therapy see [71]).
“Emotional support and case finding” constitutes 
a novel perspective on how to organize the clinical 
management of emotions in patients with cancer. As 
such, neither support nor case finding is new. The 
novelty of this approach lies in clearly articulating 
this approach and providing a rationale for this ap-
proach. This represents a significant improvement 
on current clinical practice: instead of poorly de-
fined and intuitive usual care, we now present an 
explicit approach to the management of emotions in 
patients with cancer and we provide the rationale for 
this approach. This provides a backbone to current 
clinical practice, the approach can be used to up-
grade clinical practice, and it informs an innovative 
research agenda (see below).
Furthermore, the fact that our approach is rather 
close to current clinical practice may facilitate im-
plementation. Oncologists and nurses recognize the 
provision of emotional support as an important clin-
ical task and they have been observed to use various 
strategies to identify patients in need of mental health 
care, as mentioned above. This is an important 
stepping-stone for successful implementation.
Finally, our approach could contribute to the pre-
vention of poor clinical outcomes. The provision of 
emotional support by the treating team is intended to 
enable patients to better adapt and cope with cancer. 
This may prevent emotions from becoming mal-
adaptive, requiring professional mental health care. 
In addition, improved management of emotions may 
prevent non-adherence to medical treatment and the 
associated poorer treatment outcomes [8].
FUTURE RESEARCH
The approach “emotional support and case finding” 
informs an innovative research agenda to further 
improve clinical practice. We suggest the following 
research agenda.
 • To explore the training needs of the treating team, and 
to develop effective and feasible training methods. 
Training may concern the assessment of emotions and 
the provision of emotional support.
• To identify risk factors for emotional problems and to 
target case finding to those patients exhibiting risk fac-
tors (e.g., lack of social support, an earlier episode of 
depression).
• To develop measurement instruments that can distin-
guish between adaptive and maladaptive emotions. 
These instruments should support and improve deci-
sion making that currently is based on clinical evalu-
ation and patient’s subjective need only.
• To optimize interventions to support patients with 
adaptive emotions as well as interventions to treat 
emotional problems in patients with maladaptive emo-
tions. Such interventions are available, but may need 
further optimization.
• To explore other factors that may influence the suc-
cessful implementation of the new approach. For ex-
ample, although oncologists and nurses recognize the 
provision of emotional support as an important clin-
ical task, in a busy clinic time to perform these tasks 
is limited. How the treating team might perform the 
proposed tasks within the constraints of daily clinical 
practice needs to be investigated. In studying factors 
that may influence the successful implementation of 
the new approach, international variation in the organ-
ization of supportive cancer care needs to be taken into 
account as well.
 •  And finally, to evaluate the extent to which clinical 
practice based on the new approach leads to enhanced 
health outcomes.
In conclusion, the approach “emotional support and 
case finding” provides a novel perspective on how 
to organize the clinical management of emotions in 
patients with cancer. This approach can be used to 
upgrade clinical practice, and it informs an innova-
tive research agenda on how to further improve clin-
ical practice.
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